Oaktree Acquisition Corp. III Life Sciences OACCW
Finances
| Revenue |
| Net income |
| Income before tax |
| Income before tax ratio |
| EBITDA |
| Net income ratio |
| Ratio EBITDA |
| Gross profit ratio |
| Weighted average shs out dil |
| Weighted average shs out |
| EPS diluted |
| Earnings per share |
| Gross profit |
| Income tax expense |
| Cost of revenue |
| General and administrative expenses |
| Selling and marketing expenses |
| Other expenses |
| Operating expenses |
| Cost and expenses |
| Research and development expenses |
| Selling general and administrative expenses |
| Interest income |
| Interest expense |
| Depreciation and amortization |
| Operating income |
| Operating income ratio |
| Total other income expenses net |
| Net debt |
| Total investments |
| Total debt |
| Accumulated other comprehensive income loss |
| Retained earnings |
| Common stock |
| Total equity |
| Other non current liabilities |
| Long term debt |
| Total non current liabilities |
| Other current liabilities |
| Deferred revenue |
| Short term debt |
| Total current liabilities |
| Total liabilities |
| Other non current assets |
| Long term investments |
| Intangible assets |
| GoodWill |
| Goodwill and intangible assets |
| Property plant equipment net |
| Total non current assets |
| Other current assets |
| Short term investments |
| cash and cash equivalents |
| Cash and short term investments |
| Total current assets |
| Inventory |
| Net receivables |
| Tax assets |
| Other assets |
| Account payables |
| Tax payables |
| Deferred revenue non current |
| Minority interest |
| Capital lease obligations |
| Preferred stock |
| Other total stockholders equity |
| Deferred tax liabilities non current |
| Other liabilities |
| Total assets |
| Deferred income tax |
| Stock based compensation |
| Change in working capital |
| Accounts receivables |
| Inventory |
| Accounts payables |
| Other working capital |
| Other non cash items |
| Net cash provided by operating activities |
| Investments in property plant and equipment |
| Acquisitions net |
| Purchases of investments |
| Sales maturities of investments |
| Other investing activites |
| Net cash used for investing activites |
| Debt repayment |
| Common stock issued |
| Common stock repurchased |
| Dividends paid |
| Other financing activites |
| Net cash used provided by financing activities |
| Effect of forex changes on cash |
| Net change in cash |
| Cash at beginning of period |
| Cash at end of period |
| Operating cash flow |
| Capital expenditure |
| Free CashFlow |
| 2025-06-30 | 2025-03-31 | |
|---|---|---|
| Revenue | 0.000 | 0.000 |
| Net income | 1.874 M 44.68 % | 1.296 M |
| Income before tax | 1.874 M 44.68 % | 1.296 M |
| Income before tax ratio | 0.00 | 0.00 |
| EBITDA | -269.810 K | 0.000 |
| Net income ratio | 0.00 | 0.00 |
| Ratio EBITDA | 0.00 | 0.00 |
| Gross profit ratio | 0.00 | 0.00 |
| Weighted average shs out dil | 19.199 M 99 900.15 % | 19.199 K |
| Weighted average shs out | 19.199 M 99 900.15 % | 19.199 K |
| EPS diluted | 0.08 -99.88 % | 67.48 |
| Earnings per share | 0.08 -99.88 % | 67.48 |
| Gross profit | 0.000 | 0.000 |
| Income tax expense | 0.000 | 0.000 |
| Cost of revenue | 0.000 | 0.000 |
| General and administrative expenses | 269.810 K | 0.000 |
| Selling and marketing expenses | 0.000 | 0.000 |
| Other expenses | 0.000 | 0.000 |
| Operating expenses | 269.810 K | 0.000 |
| Cost and expenses | 0.000 | 0.000 |
| Research and development expenses | 0.000 | 0.000 |
| Selling general and administrative expenses | 269.810 K | 0.000 |
| Interest income | 0.000 | 0.000 |
| Interest expense | 0.000 | 0.000 |
| Depreciation and amortization | 0.000 | 0.000 |
| Operating income | -269.810 K | 0.000 |
| Operating income ratio | 0.00 | 0.00 |
| Total other income expenses net | 2.144 M | 0.000 |
| 2025-06-30 | 2025-03-31 |
| 2025-06-30 | 2025-03-31 | |
|---|---|---|
| Net debt | -1.385 M -8.11 % | -1.281 M |
| Total investments | 0.000 | 0.000 |
| Total debt | 0.000 | 0.000 |
| Accumulated other comprehensive income loss | 0.000 | 0.000 |
| Retained earnings | -6.540 M -0.30 % | -6.520 M |
| Common stock | 396.753 M 0.97 % | 392.924 M |
| Total equity | -6.539 M | 0.000 |
| Other non current liabilities | 7.019 M 0.00 % | 7.019 M |
| Long term debt | 0.000 | 0.000 |
| Total non current liabilities | 7.019 M 0.00 % | 7.019 M |
| Other current liabilities | 1.119 M 5.74 % | 1.059 M |
| Deferred revenue | 0.000 | 0.000 |
| Short term debt | 0.000 | 0.000 |
| Total current liabilities | 1.119 M 5.74 % | 1.059 M |
| Total liabilities | 8.138 M 0.75 % | 8.077 M |
| Other non current assets | 197.615 M 0.95 % | 195.758 M |
| Long term investments | 0.000 | 0.000 |
| Intangible assets | 0.000 | 0.000 |
| GoodWill | 0.000 | 0.000 |
| Goodwill and intangible assets | 0.000 | 0.000 |
| Property plant equipment net | 0.000 | 0.000 |
| Total non current assets | 197.615 M 0.95 % | 195.758 M |
| Other current assets | 175.783 K -12.54 % | 200.979 K |
| Short term investments | 0.000 | 0.000 |
| cash and cash equivalents | 1.385 M 8.11 % | 1.281 M |
| Cash and short term investments | 1.385 M 8.11 % | 1.281 M |
| Total current assets | 1.561 M 5.31 % | 1.482 M |
| Inventory | 0.000 | 0.000 |
| Net receivables | 0.000 | 0.000 |
| Tax assets | 0.000 | 0.000 |
| Other assets | 0.000 | 0.000 |
| Account payables | 0.000 | 0.000 |
| Tax payables | 0.000 | 0.000 |
| Deferred revenue non current | 0.000 | 0.000 |
| Minority interest | 0.000 | 0.000 |
| Capital lease obligations | 0.000 | 0.000 |
| Preferred stock | 0.000 | 0.000 |
| Other total stockholders equity | 0.000 | 0.000 |
| Deferred tax liabilities non current | 0.000 | 0.000 |
| Other liabilities | 0.000 | 0.000 |
| Total assets | 199.176 M 0.98 % | 197.241 M |
| 2025-06-30 | 2025-03-31 |
| 2025-06-30 | |
|---|---|
| Deferred income tax | 0.000 |
| Stock based compensation | 0.000 |
| Change in working capital | -214.024 K |
| Accounts receivables | 0.000 |
| Inventory | 0.000 |
| Accounts payables | -153.961 K |
| Other working capital | 0.000 |
| Other non cash items | -2.071 M |
| Net cash provided by operating activities | -131.998 K |
| Investments in property plant and equipment | 0.000 |
| Acquisitions net | 0.000 |
| Purchases of investments | 0.000 |
| Sales maturities of investments | 0.000 |
| Other investing activites | 250.000 K |
| Net cash used for investing activites | 250.000 K |
| Debt repayment | 0.000 |
| Common stock issued | 0.000 |
| Common stock repurchased | 0.000 |
| Dividends paid | -4.248 M |
| Other financing activites | 4.248 M |
| Net cash used provided by financing activities | 0.000 |
| Effect of forex changes on cash | 0.000 |
| Net change in cash | 28.315 K |
| Cash at beginning of period | 1.357 M |
| Cash at end of period | 1.385 M |
| Operating cash flow | -131.998 K |
| Capital expenditure | 0.000 |
| Free CashFlow | -131.998 K |
| 2025 |
| Date | Form 10K |
|---|